Kymeratx

Developer of small molecule protein degraders for multiple disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups150 employees language kymeratx.com

Registered entities

Social engagement

Social engagement: 45.2K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

24 investors on record; lead investors include Redmile Group, Foresite Capital, 6 Dimensions Capital, Bessemer Venture Partners; 1 has since exited.

Investor typeCountShare
Venture capital1771%
Private equity14%
Accelerator & incubator14%
Other / undisclosed521%

Recent activity

25 Jun 2026
Milestone
regulatory
17 Jun 2026
Event
Revolutionizing Atopic Dermatitis conference
9 Jun 2026
Milestone
regulatory
Coming soon